Genzyme related Press Releases
Genzyme Corporation Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Genzyme Corporation Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease March 19, 2009 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ)
... Read more...Genzyme Biosurgery Shareholders Receive $64 Million Settlement in Victory Over Genzyme Corporation (GENZ)
Genzyme Biosurgery Shareholders Receive $64 Million Settlement in Victory Over Genzyme Corporation (GENZ) January 13, 2009 NEW YORK--(BUSINESS WIRE)--Shareholders of Genzyme Biosurgery
... Read more...FDA Approves Genzyme Corporation (GENZ)'s Mozobil
FDA Approves Genzyme Corporation (GENZ)'s Mozobil CAMBRIDGE, Mass., Dec 15, 2008 (BUSINESS WIRE) -- Genzyme Corporation announced today that the U.S. Food and Drug Administration has granted
... Read more...Genzyme Seeks U.S. Approval for Clolar® to Treat Adult AML
Genzyme Seeks U.S. Approval for Clolar® to Treat Adult AML Indication Would Address Significant Unmet Medical Need and Expand Product Use CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation
... Read more...Genzyme Reports Strong Third-Quarter Sales and Earnings Growth
Genzyme Reports Strong Third-Quarter Sales and Earnings Growth Company Expects 2009 Non-GAAP EPS of Approximately $4.70 October 22, 2008--CAMBRIDGE, Mass.--(
... Read more...FDA Advisory Panel to Discuss Genzyme's Myozyme BLA on Tuesday
Genzyme Begins Enrollment in Post-Marketing Study to Evaluate Use of Low Dose Fabrazyme Treatment for Fabry Disease
Science survey ranks top biopharma employers
Genzyme Corporation (GENZ) Marks Grand Opening of $125 Million Science Center; Among the First Research Laboratories to Earn Gol
Genzyme Corporation and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics to Accelerate Discove
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges




